Biogen (BIIB) Change in Cash (2009 - 2026)

Biogen's Change in Cash history runs 18 years deep, the most recent figure standing at -$2.1 billion for Q2 2026.

• In Q2 2026, Change in Cash fell 2371.48% year-over-year to -$2.1 billion; the TTM figure through Jun 2026 stood at -$1.5 billion (down 286.28% YoY), while the FY2025 annual figure was $531.6 million, down 61.83% from the prior year.
• Change in Cash for Q2 2026 stood at -$2.1 billion, down from $392.2 million in the prior quarter.
• The five-year high for Change in Cash was $1.1 billion in Q3 2025, with the low at -$2.1 billion in Q2 2026.
• The 5-year median for Change in Cash is -$102.2 million (2024), against an average of -$53.8 million.
• The sharpest annual moves came in 2022 and 2026: Change in Cash jumped 718.59% in 2022, then slumped 2371.48% in 2026.
• Biogen's Change in Cash stood at -$323.5 million in 2022, then sank by 297.5% to -$1.3 billion in 2023, then soared by 158.34% to $750.2 million in 2024, then tumbled by 214.21% to -$856.8 million in 2025, then slumped by 144.43% to -$2.1 billion in 2026.
• Business Quant data shows BIIB's Change in Cash at -$2.1 billion in Q2 2026, $392.2 million in Q1 2026, and -$856.8 million in Q4 2025.